MayTech Global Investments’s Alexion Pharmaceuticals ALXN Stock Holding History

MayTech Global Investments’s Portfolio ALXN Stock Details ALXN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-200	Closed	-$37K	–	73
2021 Q2	$37K	Hold	200	–	–	0.01%	54
2021 Q1	$31K	Hold	200	–	–	0.01%	48
2020 Q4	$31K	Hold	200	–	–	0.01%	47
2020 Q3	$23K	Hold	200	–	–	0.01%	44
2020 Q2	$22K	Hold	200	–	–	0.01%	45
2020 Q1	$18K	Hold	200	–	–	0.01%	43
2019 Q4	$22K	Buy	+200	New	+$21.4K	0.01%	44
2019 Q3	–	Sell	-200	Closed	-$26K	–	54
2019 Q2	$26K	Hold	200	–	–	0.01%	39
2019 Q1	$27K	Hold	200	–	–	0.01%	39
2018 Q4	$19K	Hold	200	–	–	0.01%	38
2018 Q3	$28K	Hold	200	–	–	0.01%	38
2018 Q2	$25K	Hold	200	–	–	0.01%	36
2018 Q1	$22K	Buy	+200	New	+$23.9K	0.01%	42

Other funds holding ALXN

BCI

Brinker Capital Investments Berwyn, Pennsylvania $13.1B AUM 28.37% 1-Year Est. Return

NICM

Neo Ivy Capital Management New York $434M AUM 44.19% 1-Year Est. Return

TAIM

TD Ameritrade Investment Management Omaha, Nebraska $9.4B AUM 7.2% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

Retirement Group San Diego, California $279M AUM 22.21% 1-Year Est. Return

CFO

CVA Family Office Denver, Colorado $1.1B AUM 26.6% 1-Year Est. Return

MAM

Meeder Asset Management Dublin, Ohio $1.96B AUM 48.96% 1-Year Est. Return

MayTech Global Investments's ALXN Position: Q3 2021 in Review

MayTech Global Investments sold out of Alexion Pharmaceuticals (ALXN) in Q3 2021, closing a stake of 200 shares — an estimated $37K sold.

MayTech Global Investments first reported a position in ALXN in Q1 2018 and held it in 13 quarters. The position peaked at $37K in Q2 2021. 7 funds tracked by Wall St. Rank hold ALXN as of Q3 2021.

MayTech Global Investments reported no remaining Alexion Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
MayTech Global Investments sold 200 Alexion Pharmaceuticals shares in Q3 2021, an estimated $37K.
MayTech Global Investments first reported a position in Alexion Pharmaceuticals in Q1 2018 and held it in 13 quarters.
MayTech Global Investments's Alexion Pharmaceuticals position peaked at $37K in Q2 2021.
7 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q3 2021.

Based on MayTech Global Investments's 13F filing for Q3 2021, filed 12 Nov 2021.